☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
licensing
Everest Enter into an Exclusive License Agreement with Sinovent and SinoMab to Develop and Commercialize XNW1011 for Renal Disease...
September 20, 2021
Simcere Signs an Exclusive Regional Licensing Agreement with GI Innovation for its GI-101 Candidate
November 28, 2019
Takeda Signs a Licensing Agreement with Curadev for Stimulator of Interferon Genes (STING) Agonist
May 9, 2019
Lilly Signs a Global Research and Licensing Agreement with Avidity Biosciences to Develop Therapies in Immunology
April 22, 2019
Nestle Health Science (NHSc) Exercises its Exclusive WorldWide Option to License CDX-6114 from Codexis
February 15, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.